(Sharecast News) - Angle's share price received a boost on Thursday after the liquid biopsy company announced a new agreement with Utah-based biotech firm Recursion Pharmaceuticals.
The agreement is confidential between the two parties, but is said to involve Angle's Parsortix technology - a unique method for capturing and harvesting intact...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE